Zhang Xuanping, Imperatore Giuseppina, Thomas William, Cheng Yiling J, Lobelo Felipe, Norris Keri, Devlin Heather M, Ali Mohammed K, Gruss Stephanie, Bardenheier Barbara, Cho Pyone, Garcia de Quevedo Isabel, Mudaliar Uma, Saaddine Jinan, Geiss Linda S, Gregg Edward W
Division of Diabetes Translation, National Centers for Chronic Disease Prevention and Health Promotion, Centers for Disease Control and Prevention, Atlanta, GA, USA.
Office of Public Health Scientific Services, Centers for Disease Control and Prevention, Atlanta, GA, USA.
Diabetes Res Clin Pract. 2017 Jan;123:149-164. doi: 10.1016/j.diabres.2016.11.020. Epub 2016 Dec 3.
This study systematically assessed the effectiveness of lifestyle interventions on glycemic indicators among adults (⩾18years) without IGT or diabetes. Randomized controlled trials using physical activity (PA), diet (D), or their combined strategies (PA+D) with follow-up ⩾12months were systematically searched from multiple electronic-databases between inception and May 4, 2016. Outcome measures included fasting plasma glucose (FPG), glycated hemoglobin (HbA1c), fasting insulin (FI), homeostasis model assessment-estimated insulin resistance (HOMA-IR), and bodyweight. Included studies were divided into low-range (FPG <5.5mmol/L or HbA1c <5.5%) and high-range (FPG ⩾5.5mmol/L or HbA1c ⩾5.5%) groups according to baseline glycemic levels. Seventy-nine studies met inclusion criteria. Random-effect models demonstrated that compared with usual care, lifestyle interventions achieved significant reductions in FPG (-0.14mmol/L [95%CI, -0.19, -0.10]), HbA1c (-0.06% [-0.09, -0.03]), FI (%change: -15.18% [-20.01, -10.35]), HOMA-IR (%change: -22.82% [-29.14, -16.51]), and bodyweight (%change: -3.99% [-4.69, -3.29]). The same effect sizes in FPG reduction (0.07) appeared among both low-range and high-range groups. Similar effects were observed among all groups regardless of lengths of follow-up. D and PA+D interventions had larger effects on glucose reduction than PA alone. Lifestyle interventions significantly improved FPG, HbA1c, FI, HOMA-IR, and bodyweight among adults without IGT or diabetes, and might reduce progression of hyperglycemia to type 2 diabetes mellitus.
本研究系统评估了生活方式干预对18岁及以上无糖耐量受损(IGT)或糖尿病的成年人血糖指标的有效性。在多个电子数据库中,系统检索了从建库至2016年5月4日期间采用体育活动(PA)、饮食(D)或其联合策略(PA+D)且随访时间≥12个月的随机对照试验。结局指标包括空腹血糖(FPG)、糖化血红蛋白(HbA1c)、空腹胰岛素(FI)、稳态模型评估的胰岛素抵抗(HOMA-IR)和体重。根据基线血糖水平,将纳入研究分为低范围组(FPG<5.5mmol/L或HbA1c<5.5%)和高范围组(FPG≥5.5mmol/L或HbA1c≥5.5%)。79项研究符合纳入标准。随机效应模型表明,与常规护理相比,生活方式干预使FPG显著降低(-0.14mmol/L[95%CI,-0.19,-0.10])、HbA1c显著降低(-0.06%[-0.09,-0.03])、FI显著降低(%变化:-15.18%[-20.01,-10.35])、HOMA-IR显著降低(%变化:-22.82%[-29.14,-16.51])以及体重显著降低(%变化:-3.99%[-4.69,-3.29])。低范围组和高范围组在FPG降低方面的效应量相同(0.07)。无论随访时间长短,所有组均观察到类似效果。D和PA+D干预在降低血糖方面的效果比单独的PA更大。生活方式干预显著改善了无IGT或糖尿病成年人的FPG、HbA1c、FI、HOMA-IR和体重,并可能减少高血糖向2型糖尿病的进展。